15 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

iFuse TORQ TNT™ Implant System

FDA 510(k)
FDA Class 2 ·Orthopedic

AXE D'ANTEVERSION POUR IMPACTEUR DE COTYLE

FDA UDI
FOURNITURES HOSPITALIERES INDUSTRIE·03661489415043·

16PW - Loggers - Poly White

FDA UDI
Certified Safety Manufacturing, Inc.·00766588015040·16PW - Loggers - Poly White

ELMED

FDA UDI
ELMED INCORPORATED·00198506057816·OLD STYLE GREENBERG BLADE 4" X 5/8"

Millennium

FDA UDI
Avalign Technologies, Inc.·00190776396442·Greenberg Retractor Blade, malleable, 5/8" x 4"

Innomed, Inc.

FDA UDI
INNOMED, INC.·00840277125040·Auerbach Rake Chain Retractor 4-Prong

Broach 50 size 4

FDA UDI
SIGNATURE ORTHOPAEDICS PTY LTD·09348215055493·

BD ULTRA-FINE¿ MINI PEN NEEDLES 5MM (3/16¿) 31G

FDA Adverse Event
Malfunction ·BECTON DICKINSON AND CO.·Product code FMI·May 2, 2019

OSSEOTITE® IMPLANT 4 X 13MM

FDA Adverse Event
Malfunction ·BIOMET 3I·Product code DZE·April 9, 2019

T-8000 THEROZONE UNIT

FDA 510(k)
FDA Class 1 ·Dental

HEMAMYST SURGICAL APPLICATOR SYSTEM, MODEL H-AS01

FDA 510(k)
FDA Class 2 ·General Hospital

LAP-BAND ADJUSTABLE GASTIC BANDING SYSTEM 9.75 CM NON US

FDA Adverse Event
Injury ·COSTA RICA·Product code LTI·November 17, 2008

SM104 M-SERIES W/5TH WHEEL

FDA Adverse Event
Malfunction ·STRYKER MEDICAL·Product code FPO·July 27, 2011

EASYTRAK 2

FDA Adverse Event
Injury ·CPI - DEL CARIBE·Product code OJX·July 22, 2013

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014